Disseminating cells in human oral tumours possess an EMT cancer stem cell marker profile that is predictive of metastasis in image-based machine learning
eLife · 17.11.2023 · 12
DOI: 10.7554/elife.90298 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, online erschienen am 17.11.2023. Verfasst von Gehad Youssef und 9 weiteren Autor:innen. Beteiligte Einrichtung: Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, Mouth Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Medical Research Council, National Centre for the Replacement Refinement and Reduction of Animals in Research.
Abstract (Originalsprache)
Cancer stem cells (CSCs) undergo epithelial-mesenchymal transition (EMT) to drive metastatic dissemination in experimental cancer models. However, tumour cells undergoing EMT have not been observed disseminating into the tissue surrounding human tumour specimens, leaving the relevance to human cancer uncertain. We have previously identified both EpCAM and CD24 as CSC markers that, alongside the mesenchymal marker Vimentin, identify EMT CSCs in human oral cancer cell lines. This afforded the opportunity to investigate whether the combination of these three markers can identify disseminating EMT CSCs in actual human tumours. Examining disseminating tumour cells in over 12,000 imaging fields from 74 human oral tumours, we see a significant enrichment of EpCAM, CD24 and Vimentin co-stained cells disseminating beyond the tumour body in metastatic specimens. Through training an artificial neural network, these predict metastasis with high accuracy (cross-validated accuracy of 87–89%). In this study, we have observed single disseminating EMT CSCs in human oral cancer specimens, and these are highly predictive of metastatic disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.
- Department of Cellular Pathology, Barts Health NHS Trust, London, United Kingdom.
ORCID-Profile: Luke Gammon, Michael P Philpott, Adrian Biddle
Förderung
- Wellcome Trust
- Medical Research Council
- National Centre for the Replacement Refinement and Reduction of Animals in Research
- Animal Free Research UK
- Oracle Cancer Trust
Zitieren
APA
Youssef, G., Gammon, L., Ambler, L., Lunetto, S., Scemama, A., Cottom, H., Piper, K., Mackenzie, I. C., Philpott, M. P., & Biddle, A. (2023). Disseminating cells in human oral tumours possess an EMT cancer stem cell marker profile that is predictive of metastasis in image-based machine learning. eLife, 12. https://doi.org/10.7554/elife.90298
Vancouver
Youssef G, Gammon L, Ambler L, Lunetto S, Scemama A, Cottom H, et al. Disseminating cells in human oral tumours possess an EMT cancer stem cell marker profile that is predictive of metastasis in image-based machine learning. eLife. 2023;12. doi:10.7554/elife.90298
BibTeX
@article{Youssef2023,
author = {Youssef, Gehad and Gammon, Luke and Ambler, Leah and Lunetto, Sophia and Scemama, Alice and Cottom, Hannah and Piper, Kim and Mackenzie, Ian C and Philpott, Michael P and Biddle, Adrian},
title = {Disseminating cells in human oral tumours possess an EMT cancer stem cell marker profile that is predictive of metastasis in image-based machine learning},
journal = {eLife},
year = {2023},
volume = {12},
doi = {10.7554/elife.90298}
}
EUVIMED